Follow this preprint
Mycobacterium tuberculosis-specific T cell activation identifies individuals at high risk of tuberculosis disease
View ORCID ProfileCheleka A.M. Mpande, Munyaradzi Musvosvi, Virginie Rozot, Boitumelo Mosito, Timothy D. Reid, Constance Schreuder, Tessa Lloyd, Nicole Bilek, Huang Huang, Gerlinde Obermoser, Mark M. Davis, Morten Ruhwald, Mark Hatherill, View ORCID ProfileThomas J. Scriba, Elisa Nemes, ACS Study Team
doi: https://doi.org/10.1101/2020.06.26.20135665
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Cheleka A.M. Mpande
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa
Munyaradzi Musvosvi
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa
Virginie Rozot
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa
Boitumelo Mosito
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa
Timothy D. Reid
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa
Constance Schreuder
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa
Tessa Lloyd
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa
Nicole Bilek
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa
Huang Huang
2Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, California, United States of America
Gerlinde Obermoser
2Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, California, United States of America
Mark M. Davis
2Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, California, United States of America
Morten Ruhwald
3Statens Serum Institut, Copenhagen, Denmark
4Foundation of Innovative New Diagnostics, Geneva, Switzerland
Mark Hatherill
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa
Thomas J. Scriba
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa
Elisa Nemes
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa
1South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, South Africa

Data Availability
Data will be available once the pre-print is published in a peer-reviewed journal
Posted June 29, 2020.
Mycobacterium tuberculosis-specific T cell activation identifies individuals at high risk of tuberculosis disease
Cheleka A.M. Mpande, Munyaradzi Musvosvi, Virginie Rozot, Boitumelo Mosito, Timothy D. Reid, Constance Schreuder, Tessa Lloyd, Nicole Bilek, Huang Huang, Gerlinde Obermoser, Mark M. Davis, Morten Ruhwald, Mark Hatherill, Thomas J. Scriba, Elisa Nemes, ACS Study Team
medRxiv 2020.06.26.20135665; doi: https://doi.org/10.1101/2020.06.26.20135665
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (420)
- Allergy and Immunology (744)
- Anesthesia (217)
- Cardiovascular Medicine (3208)
- Dermatology (270)
- Emergency Medicine (476)
- Epidemiology (13211)
- Forensic Medicine (19)
- Gastroenterology (887)
- Genetic and Genomic Medicine (5039)
- Geriatric Medicine (469)
- Health Economics (770)
- Health Informatics (3167)
- Health Policy (1121)
- Hematology (419)
- HIV/AIDS (997)
- Medical Education (467)
- Medical Ethics (125)
- Nephrology (512)
- Neurology (4783)
- Nursing (253)
- Nutrition (708)
- Oncology (2463)
- Ophthalmology (698)
- Orthopedics (277)
- Otolaryngology (336)
- Pain Medicine (318)
- Palliative Medicine (89)
- Pathology (528)
- Pediatrics (1272)
- Primary Care Research (546)
- Public and Global Health (7343)
- Radiology and Imaging (1662)
- Respiratory Medicine (962)
- Rheumatology (471)
- Sports Medicine (413)
- Surgery (532)
- Toxicology (69)
- Transplantation (227)
- Urology (199)